I agree Grantjo but the illiquid micro biotech market won't put a value on anything until it turns up as cash receipts in consecutive quarterlies. As we know, CDY is not unique in this respect.
For me it is the market failure that presents the opportunity.
AGM next week and a Wholesale Investor presentation beforehand. Will there be news? I know not but remain hopeful.
cheers
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.977M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $1.885K | 272.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 680000 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1103713 | 3 |
View Market Depth
| Last trade - 15.53pm 11/07/2025 (20 minute delay) ? |
| AN1 (ASX) Chart |